title: Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma.
abstract: The prognosis of malignant melanoma remains poor in spite of recent advances in therapeutic strategies for the deadly disease. Fisetin, a dietary flavonoid is currently being investigated for its growth inhibitory properties in various cancer models. We previously showed that fisetin inhibited melanoma growth in vitro and in vivo. Here, we evaluated the molecular basis of fisetin induced cytotoxicity in metastatic human melanoma cells. Fisetin treatment induced endoplasmic reticulum (ER) stress in highly aggressive A375 and 451Lu human melanoma cells, as revealed by up-regulation of ER stress markers including IRE1α, XBP1s, ATF4 and GRP78. Time course analysis indicated that the ER stress was associated with activation of the extrinsic and intrinsic apoptotic pathways. Fisetin treated 2-D melanoma cultures displayed autophagic response concomitant with induction of apoptosis. Prolonged treatment (16days) with fisetin in a 3-D reconstituted melanoma model resulted in inhibition of melanoma progression with significant apoptosis, as evidenced by increased staining of cleaved Caspase-3 in the treated constructs. However, no difference in the expression of autophagic marker LC-3 was noted between treated and control groups. Fisetin treatment to 2-D melanoma cultures resulted in phosphorylation and activation of the multifunctional AMP-activated protein kinase (AMPK) involved in the regulation of diverse cellular processes, including autophagy and apoptosis. Silencing of AMPK failed to prevent cell death indicating that fisetin induced cytotoxicity is mediated through both AMPK-dependent and -independent mechanisms. Taken together, our studies confirm apoptosis as the primary mechanism through which fisetin inhibits melanoma cell growth and that activation of both extrinsic and intrinsic pathways contributes to fisetin induced cytotoxicity.
authors.affiliation: Department of Dermatology, University of Wisconsin, Madison.
authors.forename: Deeba N
authors.initials: DN
authors.lastname: Syed
authors.affiliation: Department of Dermatology, University of Wisconsin, Madison.
authors.forename: Rahul K
authors.initials: RK
authors.lastname: Lall
authors.affiliation: Department of Dermatology, University of Wisconsin, Madison.
authors.forename: Jean Christopher
authors.initials: JC
authors.lastname: Chamcheu
authors.affiliation: Department of Dermatology, University of Wisconsin, Madison.
authors.forename: Omar
authors.initials: O
authors.lastname: Haidar
authors.affiliation: Department of Dermatology, University of Wisconsin, Madison.
authors.forename: Hasan
authors.initials: H
authors.lastname: Mukhtar
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D001343:Autophagy / Q000187:drug effects; D053148:Caspase 3 / Q000378:metabolism; D045744:Cell Line, Tumor; D000091342:Endoplasmic Reticulum Chaperone BiP; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects*; D005419:Flavonoids / Q000494:pharmacology*; D044948:Flavonols; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009569:Nitric Oxide / Q000096:biosynthesis; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000091342:Endoplasmic Reticulum Chaperone BiP; D005419:Flavonoids; D044948:Flavonols; C000717247:HSPA5 protein, human; D017382:Reactive Oxygen Species; D009569:Nitric Oxide; D000255:Adenosine Triphosphate; D055372:AMP-Activated Protein Kinases; C505407:CASP3 protein, human; D053148:Caspase 3; C017875:fisetin
keywords: Cytotoxicity; Fisetin; Melanoma